title: Surgical management of lung cancer invading the aorta or the superior vena cava.
abstract: OBJECTIVE
  Invasion of mediastinal structures (T4) is considered as an absolute contraindication to surgical management of non-small cell lung cancer (NSCLC). The authors studied the role of surgical treatment in case of direct aortic and superior venous caval involvement.
  
  
  METHODS
  From 1995 to 2000, 13 patients with left lung NSCLC invading descending aorta and 9 patients with right upper lobe NSCLC and superior vena cava (SVC) invasion were subjected to thoracotomy for lung resection. Surgery was indicated in case of absence of intraluminal extension. All patients were cN2 negative. The pathology results and 5-year survival were recorded and analyzed.
  
  
  RESULTS
  In three cases (23%) the tumor was adhered to the parietal pleura overlying descending aorta, which was resected en block with tumor-associated lung parenchyma. Aortic adventitia invasion by tumor led to local resection of adventitia (<1cm(2)) in nine patients (69%). Invasion deeper than adventitia was encountered in one case (8%), which was managed with aortic partial occlusion, resection of aortic wall and repair of the defect with Gore graft patch. In three patients (33%) the SVC wall was involved by the tumor 1-3cm in length and 2-4mm of the circumference. The defect was repaired with direct suturing. In five patients (56%) the area of SVC wall that was invaded was 3cmx2cm. The defect was repaired with Dacron patch. In 1 patient (11%) an arterial 14 graft was end-to-end interposed. All resections were radical (R0). Neither associated postoperative complications nor operative mortality was recorded. Five-year survival was 30.7% for the cases with aortic invasion and 11% for the ones with SVC involvement.
  
  
  CONCLUSIONS
  Radical surgical resection of lung tumors with localized aortic invasion can be considered after exclusion of N2 involvement.
authors.affiliation: Sismanogleio General Hospital, Thoracic Surgery Department, Athens, Greece. panmisthos@yahoo.gr
authors.forename: P
authors.initials: P
authors.lastname: Misthos
authors.forename: G
authors.initials: G
authors.lastname: Papagiannakis
authors.forename: J
authors.initials: J
authors.lastname: Kokotsakis
authors.forename: G
authors.initials: G
authors.lastname: Lazopoulos
authors.forename: E
authors.initials: E
authors.lastname: Skouteli
authors.forename: A
authors.initials: A
authors.lastname: Lioulias
mesh_terms: D001011:Aorta / Q000473:pathology / Q000601:surgery*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D015996:Survival Rate; D019616:Thoracic Surgical Procedures; D016896:Treatment Outcome; D014683:Vena Cava, Superior / Q000473:pathology / Q000601:surgery*